Although the larger number of results confirm the increase of Ser(P)-1292 LRRK2 in urine-derived EVs from PD patients, there are still several aspects that need to be better investigated before considering LRRK2 in EVs as a suitable biomarker for PD. The gene discussed is LRRK2; the disease is Parkinson disease.